Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-26-026014
Filing Date
2026-04-20
Accepted
2026-04-20 16:36:46
Documents
1
Period of Report
2025-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1776717403.html 4  
1 FORM 4 wk-form4_1776717403.xml 4 6143
  Complete submission text file 0001628280-26-026014.txt   7800
Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Issuer) CIK: 0001826667 (see all company filings)

EIN.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address BOX 984 BORAS V7 SE-501 10
Business Address BOX 984 BORAS V7 SE-501 10 46 (0) 705-27 13 50
Frankenius Equity AB (Reporting) CIK: 0001988262 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39813 | Film No.: 26875519